Efficacy and safety of taletrectinib in patients (Pts) with ROS1+non-small cell lung cancer (NSCLC): Interim analysis of global TRUST-II study-MedSci.cn

Efficacy and safety of taletrectinib in patients (Pts) with ROS1+non-small cell lung cancer (NSCLC): Interim analysis of global TRUST-II study

Perol, M; Yang, N; Choi, CM; Ohe, Y; Sugawara, S; Yanagitani, N; Liu, G; De Braud, FGM; Nieva, J; Nagasaka, M; Bazhenova, L; Zhou, C; Felip, E; Zhang, X; Li, S; Pennell, NA

ANNALS OF ONCOLOGY, 2023; 34 ():

科室
- - 订阅+
  - 更多科室
工具
服务